N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4,5-dimethoxy-1H-indole-2-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-pyrrolidin-1-ylpyrimidine-5-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-[[3-(trifluoromethyl)phenyl]methyl]pyridine-3-carboxamide
C124H143F3N20O14 — CID 158030598
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4,5-dimethoxy-1H-indole-2-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-pyrrolidin-1-ylpyrimidine-5-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-[[3-(trifluoromethyl)phenyl]methyl]pyridine-3-carboxamide
N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4,5-dimethoxy-1H-indole-2-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-pyrrolidin-1-ylpyrimidine-5-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-[[3-(trifluoromethyl)phenyl]methyl]pyridine-3-carboxamide (PubChem CID 158030598) has the molecular formula C124H143F3N20O14 and a molecular weight of 2194.63 g/mol. Its IUPAC name is N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4,5-dimethoxy-1H-indole-2-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-pyrrolidin-1-ylpyrimidine-5-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-[[3-(trifluoromethyl)phenyl]methyl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4,5-dimethoxy-1H-indole-2-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-pyrrolidin-1-ylpyrimidine-5-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-[[3-(trifluoromethyl)phenyl]methyl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 158030598 |
| Molecular Formula | C124H143F3N20O14 |
| Molecular Weight | 2194.63 g/mol |
| Exact Mass | 2193.10 |
| IUPAC Name | N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4,5-dimethoxy-1H-indole-2-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-pyrrolidin-1-ylpyrimidine-5-carboxamide;N-[4-[3-(dibutylcarbamoyl)-5-methylpyrazol-1-yl]-3-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-2-[[3-(trifluoromethyl)phenyl]methyl]pyridine-3-carboxamide |
| SMILES | CCCCN(CCCC)C(=O)c1cc(C)n(-c2ccc(NC(=O)c3cc4c(OC)c(OC)ccc4[nH]3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1.CCCCN(CCCC)C(=O)c1cc(C)n(-c2ccc(NC(=O)c3cccnc3Cc3cccc(C(F)(F)F)c3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1.CCCCN(CCCC)C(=O)c1cc(C)n(-c2ccc(NC(=O)c3cnc(N4CCCC4)nc3)cc2C(=O)N2Cc3ccccc3C[C@H]2CO)n1 |
| InChI | InChI=1S/C44H47F3N6O4.C41H48N6O6.C39H48N8O4/c1-4-6-20-51(21-7-5-2)43(57)39-22-29(3)53(50-39)40-18-17-34(26-37(40)42(56)52-27-32-14-9-8-13-31(32)25-35(52)28-54)49-41(55)36-16-11-19-48-38(36)24-30-12-10-15-33(23-30)44(45,46)47;1-6-8-18-45(19-9-7-2)41(51)35-20-26(3)47(44-35)36-16-14-29(42-39(49)34-23-31-33(43-34)15-17-37(52-4)38(31)53-5)22-32(36)40(50)46-24-28-13-11-10-12-27(28)21-30(46)25-48;1-4-6-16-44(17-7-5-2)38(51)34-20-27(3)47(43-34)35-15-14-31(42-36(49)30-23-40-39(41-24-30)45-18-10-11-19-45)22-33(35)37(50)46-25-29-13-9-8-12-28(29)21-32(46)26-48/h8-19,22-23,26,35,54H,4-7,20-21,24-25,27-28H2,1-3H3,(H,49,55);10-17,20,22-23,30,43,48H,6-9,18-19,21,24-25H2,1-5H3,(H,42,49);8-9,12-15,20,22-24,32,48H,4-7,10-11,16-19,21,25-26H2,1-3H3,(H,42,49)/t35-;30-;32-/m000/s1 |
| InChIKey | FHDDFSJPMMWDOX-SWVMEUPFSA-N |
| XLogP | 20.00 |
| TPSA | 399.47 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 41 |
| Heavy Atoms | 161 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2194.63 |
| LogP ≤ 5 | 20.00 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 24 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158030598 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.